Allergy Therapeutics Share Discussion Threads

[mykai] 13/3/2014 13:34

Cube

Are you in anything else worth watching at the moment, i have no secrets OPAY,FLX,THT and a few other bits and a bit of cash looking for a good home

[mykai] 13/3/2014 13:34

Cube

Are you in anything else worth watching at the moment, i have no secrets OPAY,FLX,THT and a few other bits and a bit of cash looking for a good home

[ayl30] 13/3/2014 13:32

Malc.....ha ha very funny!

[malcolmdgama04] 13/3/2014 13:22

So when does AGY flaot or isnt a date set yet ?

[malcolmdgama04] 13/3/2014 13:18

Thanks mirabeau.

[mirabeau] 13/3/2014 13:12

m04

There is no commercial relationship but they both operate in the same medical field of allergy treatments (cat allergies, pollen etc etc)

[malcolmdgama04] 13/3/2014 13:09

i know this might be a silly question but whats CIRCASSIA relationship wiht AGY ?

[cube boss] 13/3/2014 13:00

Because we are all full to the brim and ready to go to the next level!.:0)

[malcolmdgama04] 13/3/2014 12:44

major reduction in share volume. only 8 trades today.. any one know why ?

[genises] 13/3/2014 12:34

good morning ss

[audigger] 13/3/2014 11:13

My record of incorrect predictions has been upheld - as flat as France so far...!

[barefoot141] 13/3/2014 10:30

Seen this before in other recovery stocks as the share price tracks sideways for a days/weeks after big rise between support and resistance (23-27 in this case). Volume then drops for a day or two to nothing and then things start to get interesting. Only a view but tend to agree this looks OK.

[jimmyloser] 13/3/2014 10:24

Good in a way. It is early and this turns on the slightest hint of direction
Steady does me nicely.

impo/looks good.

[barefoot141] 13/3/2014 10:20

Jimmy - no volume in AGY at all here today?

[jimmyloser] 13/3/2014 10:17

Imperial Innovations Group plc (AIM: IVO, "Innovations", "the Group") is pleased to note that its largest portfolio company, Circassia Pharmaceuticals ("Circassia" or "the Company"), has today announced the successful pricing of its IPO on the London Stock Exchange's Main Market.
Circassia is expected to raise gross proceeds of approximately GBP200m. The offer price has been set at 310p pence per Ordinary Share. Innovations has an interest in Circassia of 26,494,750 shares, which at the offer price is worth GBP82.1m at the start of conditional dealings in the shares at 8.00am today. This compares with a fair value of GBP45.1m at the Group's last reporting date of 31 July 2013.
Innovations has invested GBP25.5m in Circassia across four funding rounds since 2006. At the offer price the value represents a 3.2x return on cash invested and an IRR of 37%.
Trading on the main market and the commencement of unconditional dealings in Circassia shares are expected to take place at 8.00am on 18 March 2014.
Russ Cummings, Chief Executive Officer, Imperial Innovations, said:
"We are delighted by the market's reception to Circassia's IPO and the resources that the fund raising will bring to the business. The Company has developed a strong technology platform that addresses a large global market with unmet medical needs.
"The additional funds will allow Circassia to fulfil its potential by accelerating the commercialisation of its highly promising late-stage clinical pipeline.
"Circassia's IPO follows closely the listing of Oxford Immunotec on NASDAQ in November 2013 and IXICO on AIM in October 2013. These IPOs demonstrate the strength in depth of our maturing portfolio and also illustrate our business model, which is to build substantial, high quality, well-funded and well-managed businesses in which we retain a meaningful stake."

[barefoot141] 13/3/2014 10:13

Circassia conditionally trading at 310 after its launch this morning on LSE

[richsawko] 13/3/2014 09:49

Can anyone please clarify something for me. The recent release of AGY figures that were announced as part of the CFR disclosure were for the period ending September 2013. The results expected in two weeks time for AGY - are they up to March 2014?

[cottoner] 13/3/2014 08:12

For info:

Conditional dealings in the Ordinary Shares will commence on the London Stock Exchange at 8.00am today under the ticker CIR. (ISIN: GB00BJVD3B28)

[cube boss] 13/3/2014 08:09

Nice find SS, this backs up what I found out yesterday, Circassia will float early next week!
Well guys looks like AGY is very undervalued!..:0)

Could see a nice rise up to the float next week, and only 7 trading days before our own results..:0)
Keep up the good work SS..:0))

[audigger] 13/3/2014 07:56

I think we're in fro a bumpy ride today with lots of MM games. Hold on tight!

[share_shark] 13/3/2014 07:16

Have you seen this ?.

This may be of some interest here.

[barefoot141] 12/3/2014 17:44

Hargreaves Lansdown message i received today reference Circassia for those who are interested...


Due to regulatory restrictions embedded in the terms of the Circassia Pharmaceuticals IPO, we are unable to subscribe to the offer for clients of our Vantage service. We hope to make the stock available for dealing on our platform once admitted to trading, expected to be the week commencing 17th March (date to be announced).

[barefoot141] 12/3/2014 16:23

Watching quietly in the wings, good support at 23 starting to form

[cube boss] 12/3/2014 16:17

Nice 300,000 buy been worked through. All very quiet here today!
Only 8 trading days to the results..:0)

[cube boss] 12/3/2014 10:44

Morning guys, Circassia will float early next week, but no exact date can be given as yet.
Only institutions where allowed to take part.
Peel Hunt are one of the joint bookrunners James Steel Tel: [phone]
J P Morgan is the other joint Bookrunner and sole sponsor Tel: [phone]

I do believe it was oversubscribed and are expecting a positive reaction when they float..
All good news for AGY.. Think the MMs are trying it on again..:0))